000 01417 a2200433 4500
005 20250512022836.0
264 0 _c19850828
008 198508s 0 0 eng d
022 _a0002-9173
024 7 _a10.1093/ajcp/84.2.197
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFortman, C S
245 0 0 _aSerum 5'-nucleotidase in patients receiving anti-epileptic drugs.
_h[electronic resource]
260 _bAmerican journal of clinical pathology
_cAug 1985
300 _a197-201 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a5'-Nucleotidase
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAlkaline Phosphatase
_xblood
650 0 4 _aCarbamazepine
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aEpilepsy
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNucleotidases
_xblood
650 0 4 _aPhenobarbital
_xtherapeutic use
650 0 4 _aPhenytoin
_xtherapeutic use
650 0 4 _aSex Factors
650 0 4 _agamma-Glutamyltransferase
_xblood
700 1 _aWitte, D L
773 0 _tAmerican journal of clinical pathology
_gvol. 84
_gno. 2
_gp. 197-201
856 4 0 _uhttps://doi.org/10.1093/ajcp/84.2.197
_zAvailable from publisher's website
999 _c2868632
_d2868632